COVID-19 and mechanical circulatory support
Copyright © 2020 Elsevier Masson SAS. All rights reserved..
Extracorporeal membrane oxygenation (ECMO) is mainly used as a rescue therapy in COVID-19 patients with severe acute respiratory distress syndrome (ARDS). More rarely, COVID-19 can be complicated by hemodynamic failure due to fulminant myocarditis or massive pulmonary embolism necessitating the implantation of venous-arterial ECMO. The management of ECMO during the COVID-19 pandemic is challenging due to some specificities related to the disease characteristics, such as the management of anticoagulation in patients with a hypercoagulable state and an increased risk of venous thromboembolism. In large retrospective cohorts, survival of ECMO-rescued COVID-19 patients with ADRS was reported to be similar to that reported in previous studies on ECMO support for severe ARDS. Full consideration of ECMO candidacy is crucial for appropriate allocation of resources.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:69 |
|---|---|
| Enthalten in: |
Annales de cardiologie et d'angeiologie - 69(2020), 6 vom: 10. Dez., Seite 360-364 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
COVID-19 et assistance circulatoire |
|---|
| Beteiligte Personen: |
Hekimian, G [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 17.12.2020 Date Revised 10.01.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ancard.2020.10.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316616893 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316616893 | ||
| 003 | DE-627 | ||
| 005 | 20231225161456.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.ancard.2020.10.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1055.xml |
| 035 | |a (DE-627)NLM316616893 | ||
| 035 | |a (NLM)33092785 | ||
| 035 | |a (PII)S0003-3928(20)30156-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Hekimian, G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 and mechanical circulatory support |
| 246 | 3 | 3 | |a COVID-19 et assistance circulatoire |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.12.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a Extracorporeal membrane oxygenation (ECMO) is mainly used as a rescue therapy in COVID-19 patients with severe acute respiratory distress syndrome (ARDS). More rarely, COVID-19 can be complicated by hemodynamic failure due to fulminant myocarditis or massive pulmonary embolism necessitating the implantation of venous-arterial ECMO. The management of ECMO during the COVID-19 pandemic is challenging due to some specificities related to the disease characteristics, such as the management of anticoagulation in patients with a hypercoagulable state and an increased risk of venous thromboembolism. In large retrospective cohorts, survival of ECMO-rescued COVID-19 patients with ADRS was reported to be similar to that reported in previous studies on ECMO support for severe ARDS. Full consideration of ECMO candidacy is crucial for appropriate allocation of resources | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Acute respiratory distress syndrome | |
| 650 | 4 | |a Anticoagulation | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coagulopathie | |
| 650 | 4 | |a ECMO | |
| 650 | 4 | |a Embolie pulmonaire | |
| 650 | 4 | |a Extracorporeal membrane oxygenation | |
| 650 | 4 | |a Fulminant myocarditis | |
| 650 | 4 | |a Massive pulmonary embolism | |
| 650 | 4 | |a Myocardite fulminante | |
| 650 | 4 | |a SDRA | |
| 700 | 1 | |a Frere, C |e verfasserin |4 aut | |
| 700 | 1 | |a Collet, J-P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annales de cardiologie et d'angeiologie |d 1968 |g 69(2020), 6 vom: 10. Dez., Seite 360-364 |w (DE-627)NLM000057096 |x 1768-3181 |7 nnns |
| 773 | 1 | 8 | |g volume:69 |g year:2020 |g number:6 |g day:10 |g month:12 |g pages:360-364 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ancard.2020.10.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 69 |j 2020 |e 6 |b 10 |c 12 |h 360-364 | ||